Showing results (141-150 of 263) with videos related to
Sort By:
Pageof 27
Cancer Research|January 1, 1992
Use of adaptive control with feedback to individualize suramin dosingH I Scher, D I Jodrell, J M Iversen, et al.Radiology|March 1, 1991
Limited small cell lung cancer: prognostic significance of a complete response to the induction phase of chemotherapy followed by thoracic irradiationJ G Armstrong, M M Rosenstein, H I Scher, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1989
Neuron-specific enolase can be used as the sole guide to treat small-cell lung cancer patients in common clinical practiceT A Splinter, D N Carney, M Teeling, et al.Cancer Chemotherapy and Pharmacology|January 1, 1992
Phase II study of ACNU as second-line treatment in small-cell lung cancer. EORTC Lung Cancer Cooperative GroupA S Planting, T A Splinter, A Ardizzoni, et al.Clinical Lung Cancer|January 21, 2004
Randomized trial of surgery versus radiotherapy in patients with stage IIIA (N2) non small-cell lung cancer after a response to induction chemotherapy. EORTC 08941T A Splinter, P E van Schil, G W Kramer, et al.Epidemiology (Cambridge, Mass.)|March 15, 2001
Is there a common etiology for the rising incidence of and decreasing survival with adenocarcinoma of the lung?M L Janssen-Heijnen, J W Coebergh, P J Klinkhamer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinomaV C Tjan-Heijnen, B Biesma, J Festen, et al.Cancer|June 28, 2000
Identification and characterization of circulating prostate carcinoma cellsZ P Wang, M A Eisenberger, M A Carducci, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinomaJ A McCaffrey, S Hilton, M Mazumdar, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1996
The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinomaM Prewett, P Rockwell, R F Rockwell, et al.Pageof 27